Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Department of Neurology, Harbin Children's Hospital, Harbin 150010, Heilongjiang Province, China.
Seizure. 2019 Mar;66:26-30. doi: 10.1016/j.seizure.2019.01.025. Epub 2019 Jan 28.
This study aimed to investigate the genetic etiology of epilepsy in a cohort of Chinese children.
Targeted next-generation sequencing (NGS) was performed for 120 patients with unexplained epilepsy, including 71 patients with early-onset epileptic encephalopathies, and 16 patients with Dravet syndrome (including three patients with a Dravet-like phenotype) but without SCN1A pathogenic variants.
Pathogenic variants of 14 genes were discovered in 22 patients (18%). A de novo KCND3 pathogenic variant (c.1174G > A, p.Val392Ile) was identified in a boy with refractory epilepsy, psychomotor regression, attention deficit, and visual decline. Pathogenic variants in other coding genes were excluded via whole exome sequencing. This KCND3 variant was previously confirmed to be pathogenic by Giudicessi, et al. However, the clinical profile was different: sudden death at 20 years old without any medical history of neurological disorders, nor with any diseases typically caused by KCND3 pathogenic variants such as Brugada syndrome, spinocerebellar ataxia type 19/22 or ataxia accompanied by epilepsy. This indicates that we have identified a new KCND3 phenotype. In addition, we also uncovered a GRIN1 pathogenic variant and a novel HCN1 pathogenic variant in the Dravet cohort.
Our study highlights the significant utility of NGS panels in the genetic diagnosis of pediatric epilepsy. Our findings indicate that KCND3 pathogenic variants may be responsible for a wider phenotypic spectrum than previously thought, by including childhood epileptic encephalopathy. Furthermore, this study provides evidence that GRIN1 and HCN1 are candidate genes for Dravet and Dravet-like phenotypes.
本研究旨在探究中国儿童癫痫的遗传病因。
对 120 名病因不明的癫痫患者(包括 71 名早发性癫痫性脑病患者和 16 名但无 SCN1A 致病性变异的 Dravet 综合征患者[包括 3 名 Dravet 样表型患者])进行靶向下一代测序(NGS)。
在 22 名患者(18%)中发现了 14 个基因的致病性变异。一名难治性癫痫、精神运动倒退、注意力缺陷和视力下降男孩携带 KCND3 新生致病变异(c.1174G > A,p.Val392Ile)。通过全外显子组测序排除了其他编码基因的致病性变异。该 KCND3 变异此前被 Giudicessi 等证实为致病性变异,但临床表型不同:20 岁时突然死亡,无任何神经疾病病史,也无任何通常由 KCND3 致病性变异引起的疾病,如 Brugada 综合征、脊髓小脑性共济失调 19/22 或伴有癫痫的共济失调。这表明我们已经确定了一种新的 KCND3 表型。此外,我们还在 Dravet 队列中发现了 GRIN1 致病性变异和一种新的 HCN1 致病性变异。
本研究强调了 NGS 面板在儿科癫痫遗传诊断中的重要作用。我们的发现表明,KCND3 致病性变异可能导致比以前认为的更广泛的表型谱,包括儿童癫痫性脑病。此外,本研究为 GRIN1 和 HCN1 是 Dravet 和 Dravet 样表型的候选基因提供了证据。